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Abstract
Scope—The gut microbiota is able to modulate host physiology through the production of 
bioactive metabolites. Our recent studies suggest that changes in gut microbiota composition upon 
prebiotics supplementation alter tissue levels of PUFA-derived metabolites in mice. However, in 
vivo evidence that gut microbes produces PUFA-derived metabolites is lacking. This study aimed 
to decipher the contribution of gut microbes versus that of the host in PUFA-derived metabolite 
production.
Methods and results—To achieve this goal, we compared the proportion of PUFA-derived 
metabolites and the expression of fatty acid desaturases in germ-free (GF) and conventionalized 
(CONV) mice fed either a low fat or Western diet.
Higher concentrations of PUFA-derived metabolites were found in the colonic contents of CONV 
mice compared to GF mice. The abundance of these metabolites in host tissues was modulated by 
dietary treatments but not by microbial status. Although microbial status did significantly 
influence desaturase expression, no correlations between host enzymes and tissue PUFA-derived 
metabolite levels were observed.
Conclusion—Together, these results highlight the ability of the gut microbiota to produce 
PUFA-derived metabolites from dietary PUFA. However, microbial production of these 
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metabolites in colonic contents is not necessarily associated with modifications of their 
concentration in host tissues.
Keywords
gut microbiota; PUFA-derived metabolites; germ-free; western diet
Introduction
The trillions of bacteria residing in the gastrointestinal tract, known collectively as the gut 
microbiota, are well-known to influence host physiology [1]. Interactions between 
microbiota and host are, among others, mediated by bacterial production of active 
metabolites such as bile acids and short chain fatty acids [2, 3].
PUFA-derived metabolites have been associated with biological properties since feeding 
CLA to humans and animals was accompanied by anti-obesogenic, anti-atherogenic, anti-
diabetogenic and anti-carcinogenic effects [13–18]. We proposed that PUFA-derived 
metabolites could be a new kind of active metabolites produced by the gut microbes. This 
hypothesis is supported by previous studies performed in ruminants indicating microbes play 
an important role in PUFA biotransformation. Rumen microbes are known to 
biohydrogenate PUFA such as linoleic acid (LA) and α-linolenic acid (α-LnA) into 
saturated fatty acid (stearic acid, C18:0) [4–6]. Through these pathways, numerous 
intermediates are also produced, including CLA (conjugated linoleic acids), CLnA 
(conjugated linolenic acids) as well as non-conjugated fatty acids such as vaccenic acid 
(trans-11-18:1). Other in vitro experiments have shown that bacteria isolated from human 
faeces are able to synthesize CLA, CLnA and vaccenic acid (trans-11-18:1) from LA or α-
LnA [7–9]. Previous studies using feces, colon and caecal contents from germ-free (GF), 
gnotobiotic and conventional rodents indicated that gut microbes were capable of 
transforming LA into CLA during in vitro incubations [10, 11]. More recently, other 
metabolites derived from the PUFA saturation pathway were found to be present at higher 
levels in tissues from conventional versus GF mice, suggesting that gut microbial 
metabolism can affect host fatty acid composition [12]. However, whether gut microbes are 
required for CLA accumulation in host tissues remains controversial.
We previously showed that high-fat diet feeding and prebiotic supplementation were 
associated with a modulation of rumenic acid (CLA cis-9, trans-11-18:2) and vaccenic acid 
(trans-11-18:1) proportions in both caecal and subcutaneous adipose tissues [22, 23]. We 
also demonstrated that, after an oral load of PUFA, PUFA-derived metabolite production 
occurs predominantly in the distal part of the gut (caecum and colon) where the bacterial 
population is dense and diverse [24]. We also showed an accumulation of these PUFA-
derived metabolites locally in the intestinal tissues. Although our previous results obtained 
in vivo in mice suggest that the gut microbiota is able to produce PUFA-derived metabolites, 
clear evidence of the implication of microbial production is lacking.
Here, we hypothesized that the gut microbiota is required for the in vivo production of 
PUFA-derived metabolites such as CLA, CLnA and non-conjugated fatty acids. To 
investigate this hypothesis, we performed a comprehensive analysis of the fatty acid profiles 
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in both the colonic contents and host tissues of GF and CONV mice fed either a low fat 
(LFD) or western diet (WD). We also evaluated the role of host enzymes, including 
desaturases such as SCD-1 (stearoyl-CoA desaturase 1) and FADS3 (fatty acid desaturase 
3), in modulating levels of PUFA-derived metabolites in host tissues to decipher the 
contribution of gut microbial metabolism versus host metabolism in modulating tissue fatty 
acid profiles. Indeed, recent studies showed that host enzymes could also modulate CLA 
profile in host tissues. Indeed, vaccenic acid (trans-11-18:1) could be desaturated into 
rumenic acid (CLA cis-9, trans-11-18:2) by a Δ9-desaturase (called stearoyl-CoA desaturase 
1, SCD-1) in rodent or human tissues [25, 26]. In addition to SCD-1, FADS3 (fatty acid 
desaturase 3), another host desaturase, was characterized last year. This enzyme is able to 
transform vaccenic acid (trans-11-18:1) into CLA trans-11, cis-13-18:2 [27].
Materials and Methods
Animals and diets
Germ-free (GF) C3H/HeN male mice were bred and reared in flexible film isolators and 
maintained under germ free conditions with a 14 h light/10h dark cycle and controlled 
temperature and humidity. GF status of the breeding isolators was routinely checked by 
analyzing fresh feces using semi-quantitative PCR for 30 cycles and the universal bacteria 
primers 8F (AGAGTTTGATCCTGGCTCAG) and 1391R (GACGGGCGGTGWGTRCA) 
as well as by aerobic and anaerobic culture on tryptic soy agar plates and Brain Heart 
Infusion, Wilkins-Chalgren and Yeast Mold broths maintained at 37°C for seven days. GF 
status of the experimental isolator was checked at least twice, once before the introduction 
of the experimental diet and once during the last week of the experiment. GF C3H/HeN (5.5 
week-old) mice were conventionalized via oral gavage with a caecal slurry from C3H/HeN 
conventional mice. Conventionalized mice (CONV) were subsequently housed in 
individually ventilated cages. Both CONV and GF mice were housed in the same animal 
room, maintained on autoclaved bedding, and fed the same autoclaved water and diet 
(LabDiets JL Rat and Mouse/Auto 6F 5K67, St. Louis, MO) during the period preceding 
introduction of experimental diets. Experimental diets were introduced nine days after 
conventionalization of C3H/HeN mice (8 mice/group) and fed for eight weeks. All animal 
procedures were conducted with the approval of the University of Nebraska-Lincoln 
Institutional Animal Care and Use Committee.
Experimental diets were prepared by Research Diets (New Brunswick, NJ) and sterilized by 
γ-irradiation (min 50 kGy, Neutron Products, Dickerson, MD). We used a customized 
Western Diet (45% kcal from fat and 17% kcal from sucrose with low maltodextrine/high 
starch compared to the D12451 formulation from Research Diets), as these mice were part 
of another experiment investigating the impact of various starches on metabolic syndrome 
that will be published elsewhere (Bindels LB, Walter J, Ramer-Tait AE). Composition of the 
experimental diets is presented in detail in Supplemental Table 1 and the fatty acid profile 
analyzed by GC-FID (gas chromatography with flame ionization detector) is presented in 
Supplemental Table 2.
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Tissue samples
Mice were euthanized using carbon dioxide. At necropsy, livers, subcutaneous adipose 
tissues (SAT), colon tissues and colon contents were weighed and immediately flash frozen 
in liquid nitrogen. A piece of SAT was also fixed in RNA later (Ambion, Life Technologies, 
Grand Island, NY). All samples were stored at −80°C until use.
Fatty acid profile analysis
To determine the fatty acid profile in colonic contents, colon tissues and SAT, we utilized 25 
mg of colonic contents, 30 mg of colon tissues or 20 mg of SAT [24]. Colonic contents, 
colon tissues and SAT and were homogenized in a methanol:chloroform mixture (1:2 V/V). 
Homogenates were filtered with Whatman filters N°1 (porosity 10 μm). Filters were rinsed 
with 2 ml of chloroform and 1 ml of methanol. Homogenates were purified successively 
with KCl 0.88% and KCl 0.88%:methanol (1:1 V/V). After centrifugation (1500g, 5 min), 
the chloroform phase was collected in new tubes and evaporated under a nitrogen flux.
The esterified fatty acids were then subjected to an alkaline hydrolysis (saponification). 
Briefly, a solution of KOH in methanol was added and incubated at 70°C for 1 hour. The 
free fatty acids were methylated by adding 0.4 ml of HCl in methanol (1.2 M) and 
incubating at 70°C for 20 minutes. FAME (fatty acid methyl esters) were then extracted with 
hexane.
Quantification of FAME was made by gas-liquid chromatography (Focus GC, Thermo-
Finnigan, Interscience, Belgium). The chromatograph was equipped with a flame ionization 
detector and a 100 m capillary column (i.d. 0.25 mm, film thickness 0.20 μm; RT-2560, 
Restek, Interscience, Belgium) using H2 as the carrier gas at a constant flow of 1.5 ml/min. 
Oven temperature was initially set at 80°C, increased by 25°C/min to 175°C (held for 10 
min), then increased by 1°C/min to 200°C (held for 15 min), and then increased again by 
5°C/min to 215°C (held for 5 min) before being decreased by 20°C/min to 80°C. The flame 
ionization detector temperature was maintained at 250°C. The identification of each peak 
was made by comparing retention times with pure FAME standards (Larodan Fine 
Chemicals AB, Malmö, Sweden).
In accordance with an approach commonly used in the literature, PUFA and PUFA-derived 
metabolites in colonic content and host tissues were presented as percentages of identified 
fatty acids (Figure 1–3). However, we obtained similar results when PUFA and PUFA-
derived metabolites were expressed in absolute amounts (mg of fatty acid/g of content or 
tissues) (Supplemental Table 3–5).
Real-time quantitative PCR
Total RNA was extracted using the TriPure isolation reagent (Roche Diagnostics Belgium, 
Vilvoorde, Belgium) according to manufacturer’s instructions, with an additional step for 
the SAT (samples were heated at 60°C for 5 min after homogenization in Tripure). RNA 
quality was checked for a subset of samples using an Agilent 2100 Bioanalyzer (Agilent 
Technologies, Santa Clara, CA). cDNA was prepared via reverse transcription of 1 μg of 
total RNA using the Kit Reverse transcription System (Promega, Leiden, The Netherlands). 
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For the liver, real-time PCR was performed with the SetpOnePlus™ real-time PCR system 
and software (Applied Biosystems, Den Ijssel, The Netherlands) using SYBR-Green (Mesa 
Fast qPCR™, Eurogentec, Seraing, Belgium) for detection. For the SAT, real-time PCR was 
performed with an Eppendorff Mastercycler ep realplex using SYBR Green (5Prime 
RealMasterMix SYBR ROX, Gaithersburg, MD) for detection. Ribosomal protein L4 
(RPL4) was chosen as housekeeping gene to normalize the data, which was analyzed 
according to the 2−ΔΔCT method [28]. Primer sequences for the targeted mouse genes are 
RPL4 F: CAAGAAGACCAAGGAGGCTGT; RPL4 R: GGTTTCTCATTTTGCCCTTG; 
SCD-1 F: CCTCTTCGGGATTTTCTACTACATG; SCD-1 R: 
GCCGTGCCTTGTAAGTTCTGT; FADS3 F: TGCTGTGGGCTGCCAGTT; FADS3 R: 
CACCCTGACAGCAACGAAGA.
Fecal microbiota analysis
Fecal microbiota composition was analyzed by 16S rRNA gene sequencing of fecal samples 
in the context of an independent project dedicated to the investigation of the impact of 
various starches on metabolic syndrome that will be published elsewhere (Bindels LB, 
Walter J, Ramer-Tait AE).
Genomic DNA was extracted from feces using a QIAamp DNA Stool Mini Kit (Qiagen, 
Valencia, CA) according to the manufacturer’s instructions, including a bead beating step in 
lysozyme-based buffer. Briefly, the V5-V6 region of the 16S rRNA gene was PCR-enriched, 
with further tailing. Amplicons were purified, quantified and sequenced using an Illumina 
Miseq (v3 kit) to produce 2x 300 bp sequencing products. Initial quality filtering of the 
reads was performed with the Illumina Software. Quality scores were visualized with the 
FastQC software (http://www.bioinformatics.babraham.ac.uk/publications.html), and reads 
were trimmed to 250 bp (R1) and 230 bp (R2) with the FASTX-Toolkit (http://
hannonlab.cshl.edu/fastx_toolkit/). Next, reads were merged with the merge-illumina-pairs 
application (with p-value = 0.02, enforced Q30 check, perfect matching to primers which are 
removed by the software, and otherwise default settings including no ambiguous nucleotides 
allowed) [29]. For samples with >20000 merged reads, a subset of 20000 reads was 
randomly selected using Mothur 1.32.1 centos 5.5 for Linux [30] to avoid large disparities in 
the number of sequences. Putative chimeras were identified against the Gold reference 
database and removed using the UPARSE pipeline implemented in USEARCH v7.0.1001 
[31]. For this study, we focused our analysis on CLA-producing bacteria previously 
identified during in vitro studies described in the literature [7–9]. Bioinformatics searches 
(BLAST) for bacteria known to produce PUFA-derived metabolites were performed on the 
dataset in order to analyze the impact of the WD on the number of CLA-producing bacteria. 
Results were expressed in percent proportions based on the total number of sequences in 
each sample. Full protocol and accession numbers are provided in supplementary materials 
and methods.
Statistical analysis
Data are presented as the mean ± SEM. Statistical significance of difference between groups 
was assessed by one-way analysis of variance (ANOVA) followed by post hoc Tukey’s 
multiple comparison test (GraphPad Prism Software, San Diego, CA, USA). P < 0.05 was 
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considered as statistically significant. Mean values with different letters are significantly 
different from one another (p<0.05) as determined by Tukey’s post hoc ANOVA statistical 
analysis. Regarding the analysis of gut microbiota composition performed only in CONV 
mice, statistical significance of difference between the 2 groups was assessed by Student t-
test (GraphPad Prism Software, San Diego, CA, USA).
Results
Synthesis of PUFA-derived metabolites in colonic contents is influenced by both microbial 
metabolism and diet
Neither microbial status of the mice (GF versus CONV) nor dietary treatment (LFD versus 
WD) altered PUFA (LA and α-LnA) proportions in colonic contents (Figure 1A and B). 
Despite no difference in PUFA proportions, we did, however, observe a clear difference 
between levels of PUFA-derived metabolites present in GF and CONV mice when all were 
fed a LFD. Specifically, proportions of CLA cis-9, trans-11-18:2, CLA trans-11, 
trans-13-18:2 and CLA trans-9, trans-11-18:2 were all significantly higher in CONV mice 
compared to GF mice (Figure 1C, E and F). Although not significant, the abundance of CLA 
trans-10, cis-12-18:2 also tended to be higher in CONV mice compared to GF mice (Figure 
1D). Levels of non-conjugated metabolites (trans-10-18:1 and trans-11-18:1) were also 
significantly increased in CONV mice compared to GF mice when all were fed a LFD 
(Figure 1G and H). WD feeding did not change PUFA (LA and α-LnA) or PUFA-derived 
metabolite proportions in colonic contents of GF mice (Figure 1). However, WD feeding did 
decrease the proportions of PUFA-derived metabolites present in the colonic contents of 
CONV mice (Figure 1C–H) even though WD feeding did not modify PUFA proportions 
(Figure 1A–B).
Levels of PUFA-derived metabolites in host tissues are influenced by diet but not by 
microbial metabolism
WD feeding of both GF and CONV mice significantly increased the presence of LA in 
colonic tissues (Figure 2A). However, tissue abundance of α-LnA was not modified by 
microbial status of the mice (GF or CONV) or by dietary treatment (LFD or WD) (Figure 
2B). In colonic tissues, proportions of the two major CLA isomers, rumenic acid (CLA 
cis-9, trans-11-18:2) and CLA trans-10, cis-12-18:2, were found to be similar among all 
treatments (Figure 2C and D), as were proportions of the minor CLA isomers trans-11, 
trans-13-18:2 and trans-9, trans-11-18:2 between GF and CONV mice fed the same diet 
(Figure 2E and F). However, their proportions were decreased in both GF and CONV mice 
fed a WD as compared to a LFD (Figure 2E and F). Levels of non-conjugated PUFA 
metabolites were not influenced by the microbial status of the mice (Figure 2G and H). 
However, the proportion of trans-10-18:1 was significantly increased in CONV mice fed a 
WD (Figure 2G). Although not significant, similar trends were also observed for vaccenic 
acid levels in the colon tissues of both GF and CONV mice fed a WD (Figure 2H).
An evaluation of the fatty acid profile in subcutaneous adipose tissue (SAT) revealed that 
LA levels were significantly increased by WD feeding of both GF and CONV mice (Figure 
3A). An opposite effect was observed for the proportion of α-LnA, which was significantly 
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decreased by WD feeding both in GF and CONV mice (Figure 3B). Rumenic acid (CLA 
cis-9, trans-11-18:2) proportions were significantly increased by WD feeding, but were not 
influenced by the microbial status of the mice (Figure 3C). WD feeding decreased 
proportions of the CLA isomers trans-11, trans-13-18:2 and trans-9, trans-11-18:2 in both 
GF and CONV mice (Figure 3E and F), a phenomenon consistent with that observed in 
colonic tissues. Of note, CLA trans-11, trans-13-18:2 was the only PUFA-derived 
metabolite whose tissue levels were regulated by microbial status (Figure 3E).
Abundance of the non-conjugated PUFA derivative trans-10-18:1 was increased by WD 
feeding of both GF and CONV mice (Figure 3G). WD feeding had no effect on vaccenic 
acid (trans-11-18:1) levels in GF or CONV mice compared to LFD feeding (Figure 3H). 
However, the proportion of vaccenic acid (trans-11-18:1) tended to be higher in CONV 
mice compared to GF mice when both were fed a LFD (Figure 3H).
Both microbial status and dietary treatment influence desaturase mRNA expression and 
desaturation ratios
Given the discrepancy between host tissues and colonic contents regarding the abundance of 
PUFA-derived metabolites, we sought to determine if changes in host enzymes could 
explain our findings. To that end, we estimated the activity and analysed the mRNA 
expression of SCD-1 (stearoyl-CoA desaturase 1), a Δ9-desaturase known to desaturate 
vaccenic acid (trans-11-18:1) into rumenic acid (CLA cis-9, trans-11-18:2) and FADS3 
(fatty acid desaturase 3), another host desaturase recently described to transform vaccenic 
acid (trans-11-18:1) into CLA trans-11, cis-13-18:2 [27].
An estimation of SCD-1 activity was performed by calculating the ratio between the product 
(cis-9-16:1) and the substrate (16:0) of this enzyme, known as the “desaturation ratio”. No 
significant differences were observed among the various treatments for the cis-9-16:1/16:0 
ratios in colon tissues (Figure 4A). In both the liver and SAT, WD feeding decreased the 
cis-9-16:1/16:0 ratios (Figure 4B and C). In the SAT, this ratio was significantly higher in 
GF mice compared to CONV mice when both were fed a LFD; however, this difference 
disappeared when a WD was fed (Figure 4C). Microbial status did not have an impact on 
hepatic cis-9-16:1/16:0 ratios (Figure 4B). No differences in the cis-9-18:1/18:0 ratios were 
observed in the colons, livers or SAT of mice from any treatment (data not shown).
Given the significant changes observed in the hepatic and SAT desaturation ratios, we 
sought to analyse desaturase mRNA expression in these tissues. No significant differences in 
FADS3 mRNA expression were observed between GF and CONV mice or between LFD 
and WD fed mice in either tissue (Figure 5A and B). In the SAT, WD feeding significantly 
decreased SCD-1 mRNA expression in both GF and CONV mice compared to LFD feeding; 
these alterations were independent of microbial status (Figure 5D). Feeding a WD 
significantly decreased hepatic SCD-1 expression in GF mice but not in CONV mice (Figure 
5C). Of note, hepatic SCD-1 mRNA expression was 1.8 fold higher in GF mice compared to 
CONV mice when a LFD was fed, but that increase was not statistically significant (p = 
0.08, Student t-test).
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Western diet feeding altered the abundance of the bacteria known to produce PUFA-
derived metabolites
Given our observations of decreased PUFA derivatives in CONV mice fed a WD, we 
performed a next-generation sequencing analysis of the fecal microbiota to determine 
changes in abundance of CLA-producing bacteria. Our analysis revealed that feeding a WD 
to CONV mice significantly decreased abundance of Lachnospiraceae family members as 
well as the species Roseburia intestinalis (Table 1). WD feeding also tended to decrease 
numbers of Roseburia hominis (Table 1). Members of the Bifidobacterium genus were 
undetectable in our analysis.
Discussion
Previous studies have suggested that the gut microbiota is capable of producing PUFA-
derived metabolites in vivo. However, studies documenting the unequivocal contribution of 
gut microbial metabolism to the synthesis of PUFA-derived metabolites were lacking. By 
comparing the levels of PUFA-derived metabolites (mainly CLA and non-conjugated fatty 
acids) present in GF and CONV mice fed either a LFD or a WD, we present clear evidence 
that the gut microbiota is required for the synthesis of dietary PUFA-derived metabolites in 
colonic contents.
For most of the FA considered as bacterial PUFA-derived metabolites (vaccenic acid; 
trans-10-18:1; rumenic acid; CLA trans-11, trans-13-18:2; CLA trans-9, trans-11-18:2), we 
observed a considerable increase of their abundance in CONV compared to GF mice when a 
LFD was fed. The higher levels of PUFA-derived metabolites in the colonic contents of 
CONV mice compared to GF mice highlight the major contribution of the gut microbiota to 
PUFA metabolite proportions found in colonic contents. The presence of some PUFA-
derived metabolites in the colonic contents of GF mice (i.e. cis-9, trans-11-18:2; trans-10, 
cis-12-18:2 or trans-11-18:1) must be interpreted as a consequence of their presence in the 
diets.
In colonic contents, WD feeding of CONV mice was associated with decreased proportions 
of PUFA-derived metabolites as compared to the LFD fed mice. This decrease in PUFA-
derived metabolites could be due to a shift in gut microbiota composition and/or activity 
induced by the WD. Indeed, WD feeding significantly decreased the fecal abundance of the 
Lachnospiraceae family members and the species Roseburia intestinalis, two bacterial taxa 
known for their in vitro production of PUFA-derived metabolites.
In a previous study where mice were force-fed vegetable oils, we observed that the fatty acid 
profiles found in intestinal tissues were in accordance with those observed in intestinal 
contents [24]. However, in the present long-term study, analysis of the PUFA-derived 
metabolites revealed discrepancies between colonic contents and host tissues (colon, SAT). 
Specifically, proportions of most PUFA-derived metabolites found in the colon tissue were 
similar between GF and CONV mice whereas the levels of these metabolites were higher in 
the colonic content of CONV mice compared to GF mice.
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Previous studies analysing the accumulation of CLA produced by gut microbes in host tissue 
provided conflicting results [10–12]. One study reported no difference in CLA accumulation 
in host tissue between GF and gnotobiotic rats whereas another study reported that LA 
supplementation led to an increased CLA content in host tissues of conventional rats but not 
in GF rats [10, 11]. Altogether, our results lead us to propose that in this study, the bacterial 
production of PUFA-derived metabolites does not influence host tissue fatty acid profiles. 
However, Kishino et al. have shown that higher levels of metabolites derived from PUFA 
saturation pathway are found in tissues of conventional but not GF mice, suggesting that gut 
microbe metabolism is able to modulate host fatty acid composition [12]. Furthermore, we 
showed in a previous study, that upon prebiotic supplementation, production of PUFA-
derived metabolites was increased and able to modulate fatty acid profile in intestinal tissue 
and SAT [22, 23]. Therefore, as only a few subset of bacteria are able to produce these 
PUFA-derived metabolites [7–9], we propose that the contribution of the gut microbial 
metabolism to tissue fatty acid profile could only become significant upon stimulation of 
these bacteria (with prebiotics for instance). It is also tempting to speculate that the FA 
profile found in colon tissues is merely influenced by the FA profile present in the diet. 
However, in the colon tissues of both GF and CONV mice, we observed higher proportions 
of the CLA isomers trans-11, trans-13-18:2 and trans-9, trans-11-18:2 in LFD fed mice 
compared to WD fed mice. These results suggest that tissue levels of these two minor 
isomers are not directly related to their concentrations in the diets, as they were present in 
higher quantity in the WD compared to the LFD.
In view of these observations, we hypothesize that host metabolism influences the 
proportion of CLA isomers found not only in colon tissue, but also in liver and SAT, and 
that some lipid moieties classically attributed to bacterial metabolism are also synthesized in 
host tissues from precursors present in the diet. Indeed, host enzymes, mainly desaturases, 
can produce CLA from vaccenic acid (MUFA; trans-11-18:1). Specifically, the host 
enzymes SCD-1 and FADS3 are able to introduce a double bond in vaccenic acid [25–27]; 
SCD-1 introduces a double bond in the Δ9 position whereas FADS3 introduces a double 
bond in the Δ13 position, leading to the formation of CLA cis-9, trans-11-18:2 and CLA 
trans-11, cis-13-18:2, respectively [25–27].
To assess the role of SCD-1 in the modulation of tissue PUFA-derived metabolite profiles, 
we estimated SCD-1 activity by calculating “desaturation ratios” in colon, liver and adipose 
tissues. Desaturation ratios describe the ratio between the MUFA produced by SCD-1 
(palmitoleic acid and oleic acid) and the corresponding saturated fatty acid used by SCD-1 
(stearic acid and palmitic acid) [32, 33]. The cis-9-16:1/16:0 ratio was decreased by WD 
feeding independently of the microbial status of the mice both in the liver and in the SAT. 
Given the modulation of desaturation ratios in the liver and SAT, we then measured the 
mRNA expression of SCD-1 and FADS3 in these tissues. FADS3 mRNA expression in the 
liver and SAT was not influenced by microbial status or dietary treatment. This finding 
indicates that modulation of FADS3 expression was not involved in the changes of PUFA-
derived metabolite proportions observed in the SAT (mainly CLA isomers trans-11, 
trans-13-18:2 and trans-9, trans-11-18:2). However, mRNA expression of FADS3 has been 
shown to not correlate with its translation rate [34]. Future studies assessing FADS3 protein 
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expression and enzymatic activity may provide additional insight into the relationship 
between this enzyme and the changes observed in PUFA-derived metabolites in host tissues. 
Hepatic SCD-1 mRNA expression was decreased by WD feeding in GF mice but not in 
CONV mice. In the SAT, SCD-1 mRNA expression was decreased by WD feeding in both 
GF and CONV mice. This observation could be linked to elevated dietary levels of MUFA 
and PUFA since it was reported that PUFA decrease SCD-1 expression [35, 36].
In conclusion, this study provides clear evidence of the contribution of the gut microbial 
metabolism in PUFA-derived metabolite synthesis and abundance of these metabolites in 
colonic content. However, the microbial production of these metabolites in colonic contents 
is not necessarily associated with modifications of their concentration in host tissues. In fact, 
some CLA and CLnA metabolites are produced by the actions of specific enzymes 
expressed in liver or adipose tissues on trans fatty acids or CLA/CLnA found in fatty diets 
that can be absorbed mostly in the jejunum. Further exploration of host metabolism related 
to the oxidation/storage of those “novel” fatty acids would therefore be of great interest.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Profiles of PUFA and PUFA-derived metabolites (CLA and non-conjugated 
metabolites) in colonic contents of GF and CONV mice fed a low fat or western diet
Results are expressed as a percentage of identified fatty acids. Data are presented as the 
mean ± SEM. Mean values with different letters are significantly different from one another 
(p<0.05) as determined by Tukey’s post hoc ANOVA statistical analysis.
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Figure 2. Profiles of PUFA and PUFA-derived metabolites (CLA and non-conjugated 
metabolites) in colon tissues of GF and CONV mice fed a low fat or western diet
Results are expressed as a percentage of identified fatty acids. Data are presented as the 
mean ± SEM. Mean values with different letters are significantly different from one another 
(p<0.05) as determined by Tukey’s post hoc ANOVA statistical analysis.
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Figure 3. Profiles of PUFA and PUFA-derived metabolites (CLA and non-conjugated 
metabolites) in the subcutaneous adipose tissue (SAT) of GF and CONV mice fed a low fat or 
western diet
Results are expressed as a percentage of identified fatty acids. Data are presented as the 
mean ± SEM. Mean values with different letters are significantly different from one another 
(p<0.05) as determined by Tukey’s post hoc ANOVA statistical analysis.
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Figure 4. SCD-1 desaturation ratios (cis-9-16:1/16:0) for colon, liver and subcutaneous adipose 
tissue (SAT) of GF and CONV mice fed a low fat or western diet
Data are presented as the mean ± SEM. Mean values with different letters are significantly 
different from one another (p<0.05) as determined by Tukey’s post hoc ANOVA statistical 
analysis.
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Figure 5. SCD-1 and FADS3 mRNA expression in liver and subcutaneous adipose tissue (SAT) 
of GF and CONV mice fed a low fat or western diet
Data are presented as the mean ± SEM. Mean values with different letters are significantly 
different from one another (p<0.05) as determined by Tukey’s post hoc ANOVA statistical 
analysis.
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Table 1
Bioinformatics analysis using BLAST searches for bacteria known to produce PUFA-derived metabolites.
LFD WD
Lachnospiraceae family 51,59 ± 1,46 46,04 ± 1,91 *
Lactobacillus genus 0,009 ± 0,0045 0,024 ± 0,0073
Roseburia intestinalis 9,71 ± 1,32 2,43 ± 0,94 ***
Roseburia hominis 2,26 ± 0,50 1,68 ± 0,35
CONV mice were fed either a low fat or a western diet. Data are expressed as relative abundance (%) normalized to the total number of sequences 
and presented as the mean ± SEM.
*p < 0.05;
***p < 0.001 as determined by a Student t-test.
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